Evidence map›Paper›PMID 42401855›Full record

SynthesisBMC endocrine disorders2026

Serum anti-Müllerian hormone levels in women following bariatric surgery: insights from a systematic review and meta-analysis.

Mohammad Sharifi, Mohammad Jalaeian Dehghani, Mohammad Amin Karimi, Ali Jafari

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mohammad SharifiDepartment of Nutrition, Food Sciences and Clinical Biochemistry, School of Medicine, Social Determinants of Health Research Center, Gonabad University of Medical Science, Gonabad, Iran.
Mohammad Jalaeian DehghaniDepartment of Operating Room, School of Paramedical Sciences, Gonabad University of Medical Sciences, Gonabad, Iran.
Mohammad Amin KarimiSchool of Medicine, Shahid Beheshti University of Medical Sciences, Arabi Ave, Daneshjoo Blvd, Tehran, Iran. m.aminkarimi72@gmail.com.ORCID http://orcid.org/0000-0002-0638-1743
Ali JafariStudent Research Committee, Department of Community Nutrition, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ajafari.nut@gmail.com.ORCID http://orcid.org/0000-0001-7343-027X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis systematic review and meta-analysis aimed to evaluate the effects of bariatric surgery on serum anti-Müllerian hormone (AMH) levels in women, highlighting potential implications for ovarian reserve and fertility management.

methodsA systematic literature search was conducted in PubMed, Web of Science, Scopus, and Embase databases up to February 2025. The included studies were observational in design (cohort, case-control, cross-sectional) and provided quantitative pre- and post-operative AMH data. Quality assessment was performed using the Newcastle-Ottawa Scale, and data were analyzed using a random-effects meta-analysis.

resultsA total of 14 studies were included in the systematic review, with 591 participants contributing to the quantitative meta-analysis. The pooled results indicated that bariatric surgery did not significantly alter AMH levels overall (WMD = 0.05 ng/mL; 95% CI: -0.66, 0.75; p = 0.897), with substantial heterogeneity among effect estimates (I² = 93.9%, p < 0.001). Subgroup analyses suggested significant AMH reductions in studies with baseline AMH > 3 ng/mL, upper age limit ≤ 35 years, longer follow-up, retrospective design, smaller sample size, and South Asian populations, while a significant increase was observed in the fertile subgroup.

conclusionsBariatric surgery was not associated with a significant overall change in serum AMH levels. Findings suggest variable AMH responses across clinical and methodological contexts; however, given substantial heterogeneity and limited reproductive outcome data, these changes should be interpreted as dynamic endocrine biomarker responses rather than direct evidence of altered ovarian reserve or fertility potential. CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

Anti-Mullerian HormoneBariatric SurgeryOvarian ReserveBiomarkersFemaleHumansAnti-Mullerian HormoneBiomarkersAnti-Müllerian hormoneBariatric surgeryMeta-analysisOvarian reservePolycystic ovary syndrome

Identifiers

PMID42401855
PMCPMC13621544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.